(Total Views: 885)
Posted On: 12/19/2021 3:02:28 PM
Post# of 36566
Docj, thank you very much. I found it in USPTO database, Olaregen bought it from “Activation Therapeutics Inc." (Gene)
I’m also checking Ii-key patent, in USPTO database, the owner is GENEREX PHARMACEUTICALS INC. there are 6 note holders, Do you know what’s the relationship between Generex Biotechnology Corporation and GENEREX PHARMACEUTICALS INC
About Ii-key patent, #7179645 expires Nov 6,2023
2008-04-04 Assignor GENEREX PHARMACEUTICALS INC.
had 6 security assignments to these 6 assignees
IROQUOIS MASTER FUND LTD.
PORTSIDE GROWTH AND OPPORTUNITY FUND
SMITHFIELD FIDUCIARY LLC
CRANSHIRE CAPITAL, L.P.
ROCKMORE INVESTMENT MASTER FUND LTD.
IROQUOIS CAPITAL OPPORTUNITY FUND, LP
I’m also checking Ii-key patent, in USPTO database, the owner is GENEREX PHARMACEUTICALS INC. there are 6 note holders, Do you know what’s the relationship between Generex Biotechnology Corporation and GENEREX PHARMACEUTICALS INC
About Ii-key patent, #7179645 expires Nov 6,2023
2008-04-04 Assignor GENEREX PHARMACEUTICALS INC.
had 6 security assignments to these 6 assignees
IROQUOIS MASTER FUND LTD.
PORTSIDE GROWTH AND OPPORTUNITY FUND
SMITHFIELD FIDUCIARY LLC
CRANSHIRE CAPITAL, L.P.
ROCKMORE INVESTMENT MASTER FUND LTD.
IROQUOIS CAPITAL OPPORTUNITY FUND, LP
(1)
(0)
